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Cellular progression to malignancy appears to require a number of distinct steps in which genetic damage in key regulatory genes accumulates.
Immortalization, or escape from senescence, is considered to be one of the first phenotypic changes. Ni2+ treatment of normal human kidney
epithelial (NHKE) cells in vitro resulted in immortalization of the cells (IHKE cells). The combined action of Ni2+ and v-Ha-ras oncogene fully trans-
formed the cells to tumorigenicity in athymic nude mice. Sequence analysis of DNA from IHKE cells revealed point mutation in the p53 gene at
codon 238 with T->C transition. These findings suggest that Ni-induced mutation in the p53 gene can be involved in the immortalization of the
NHKE cells. The results also show that changes in the responses to EGF and TGFP and in the expression of their receptors occur during malignant
progression in vitro. - Environ Health Perspect 102(Suppl 3):117-118 (1994).
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Introduction
Substantial amounts of potentially toxic
metals have been introduced into the envi-
ronment. There is a concern that workers
exposed to some metals might have an
increased incidence of cancer. A number of
epidemiologic and laboratory animal stud-
ies have demonstrated the carcinogenicity
of nickel compounds (1-3). However, lit-
tle is known about the molecular mecha-
nism(s) of nickel carcinogenesis. Tumor
development consists ofmultistep accumu-
lations of both genetic and epigenetic
changes. Accumulating evidence indicates
that mutations in the p53 gene are the
most common genetic change in human
cancers (4). Recent studies indicate that
nickel carcinogenesis may be mediated
through oxidative genotoxic effects (5,6).
Higinbotham et al. found that nickel sub-
sulfide induces GGT to GTT transversions
in codon 12 of the K-ras oncogene in rat
renal sarcomas (7).
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In vitro model systems have been devel-
oped to facilitate the study ofcarcinogene-
sis, i.e., the causative agents of neoplasia
and cancer progression at the cellular and
molecular genetic levels. We have recently
developed an in vitro human multistep
model for the study of human epithelial
carcinogenesis (8,9). The present report
describes results obtained following nickel
treatment ofnormal diploid human kidney
epithelial cells and subsequent transfection
with the v-Ha-rasoncogene.
Materials and Methods
Cells andCell Culture
Normal human kidney epithelial (NHKE)
cells were initiated from kidney explants of
fetuses from midtrimester therapeutic abor-
tions (8). Cells were routinely cultured in a
MEM medium supplemented with EGF
(10 ng/ml), insulin (5 )ig/ml), hydrocorti-
zone (5x10-7M), transferrin (5 pg/ml), and
5% FCS. The immortalized human kidney
epithelial cell line (ILHKE) and tumori-
genic human kidney epithelial (2THKE)
cell lines were cultured with the same
medium, but FCS was reduced to 1%
(8,9).
Transformation Protocol
NHKE cells were transformed into
immortal cell line (IHKE) by continous
exposure to Ni2, (5 jig/ml) for 70 to 100
days (8,9). The IHK.E cells were trans-
fected with pZip-ras DNA and positive
clones were selected by G418 sulfate (9).
TumorigenicityEvaluation
IHKE cells and G418-resistant cell clones
were tested for tumorigenicity in athymic
nude mice.
p53Analysis
Location of p53 protein was assayed
immunocytochemically with monoclonal
antibodies Pab 1801 and Pab 421
(Oncogene Science, Inc., Manchester,
NY). Details ofthe PCR amplification and
sequencing have been published elsewhere
(10).
Results and Discussion
The immortalization of NHKE cells by
Ni2+ has been described in detail by Tveito
et al. (8). Following Ni2+ treatment, the
cells aquired an indefinite life-span in cul-
ture, produced colonies in soft agar, but
did not undergo neoplastic transformation.
Figure 1. Immunohistochemical staining of p53 in IHKE
cells x630. Reproduced with permission from Mehle et
al. (10).
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Figure 2. Genomic analysis of the p53 gene (A) wild-
Otype sequence; (B) IHKE cells with a T-*C transition in
codon 238. Reproduced with permission from Maehle et
al. (JO).
Common for the IHKE cells were abnor-
malities of chromosomes 1, 7, 9, 11, 13,
14, and 20, increased number of chromo-
some 17, and loss of normal chromosomes
20 and 22 (8).
The studies were extended to include
transfection of the IHKE cells with the
plasmid pZipNeo SV(X) containing the v-
Ha-ras gene. We found that cells derived
from the G418-resistant cell clones formed
tumors in athymic mice. The cells from
Ni-treated cells produced no tumors in this
assay (9).
At present little is known about the pro-
gression of cells from normal proliferative
control to malignancy. There is, however,
increasing evidence linking development and
progression of cancer to accumulation of
mutations (11,12). Alterations offunctional
genes associated with cellular proliferation
and differentiation, i.e., oncogenes and
tumor suppressor genes, are required during
oncogenesis leading to deregulation of the
mitogenic program.
One gene implicated in the pathogene-
sis of human cancer is the p53 gene.
Studies suggest that thep53 gene is a mol-
ecular target for genetic damages caused by
environmental factors (13). The p53 gene
is located on band 13p ofchromosome 17
and acts as a tumor suppressor. In an
attempt to explore targets of mutation by
nickel, we examined whether mutation in
the p53 gene has occurred in IHKE cells.
Immunochemistry and sequence analysis
of DNA from IHKE cells revealed abnor-
mal p53 expression and a T->C transition
mutation in codon 238. Our studies show
that mutation ofthep53 gene are not suf-
ficient for tumor formation, but the com-
bined action of Ni2+ and transfection of
the v-Ha-ras oncogene converted the
immortalized cells to tumorigenic cells.
Studies have shown that mutant p53 gene
in cooperation with Ha-ras gene trans-
forms rodent fibroblasts to neoplastic cells
(14).
Cell growth in vitro is controlled by
growth factors. The IHKE and THKE
cells demonstrated altered growth capacity
in serum-free media. In recent years, it has
become apparent that TGFO and EGF
play an important role in the regulation of
cell growth ofboth normal and malignant
epithelial cells. TGFO consists of a family
of closely related polypeptides with multi-
ple biologic activities (15). It is a potent
inhibitor of normal epithelial cell growth.
TGFO can also induce proliferation of
some cell types, such as fibroblastic cells.
Malignant epithelial cells may be resistant
to the growth-inhibitory effects ofTGF,.
Studies indicate that this resistance to
TGFP may be an important step in car-
cinogenesis (15). EGF influences many
biologic responses of both normal and
malignant cells and EGF-receptor overex-
pression has been shown in human malig-
nant epithelial cell lines and tumors (16).
In preliminary studies we have found that
the IHKE cells are resistant to high con-
centrations ofTGF,. On the other hand,
the normal cells were inhibited by TGFP.
NHKE cells were stimulated by EGF. In
contrast, IHKE cells showed reduced sen-
sitivity to growth stimulation by EGF.
NHKE cells had fewer EGF receptors than
IHKE cells and IHKE cells had fewer
TGFI receptors than NHKE cells (S.
Mollerup et al., unpublished). We are cur-
rently examining in detail the importance
of EGF and TGFI in the progression to
malignancy.
In conclusion, we have shown that
Ni2+ induces immortalization and muta-
tion in the p53 tumor suppressor gene in
normal human epithelial cells.
Furthermore, preliminary data suggest that
the Ni-induced transformation is associ-
ated with abrogation of EGF and TGF,
growth control.
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